Vyome Holdings (HIND) Current Assets (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Current Assets of $9.2 million for Q1 2026, up 45.55% year-over-year from $6.3 million in Q1 2025, and up 68.48% quarter-over-quarter from $5.4 million in Q4 2025.
Vyome Holdings (HIND) Current Assets (2015 - 2026) Analysis & Trends
Vyome Holdings' Current Assets history runs 12 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Current Assets rose 45.55% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (up 45.55% YoY), while the FY2025 annual figure was $5.4 million, up 1700.49% from the prior year.
- Current Assets for Q1 2026 stood at $9.2 million, up from $5.4 million in the prior quarter.
- The five-year high for Current Assets was $23.3 million in Q1 2022, with the low at $302046.0 in Q4 2024.
- The 5-year median for Current Assets is $8.9 million (2025), against an average of $9.7 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets sank 97.07% in 2024, then soared 1700.49% in 2025.
- Vyome Holdings' Current Assets stood at $9.9 million in 2022, then increased by 3.88% to $10.3 million in 2023, then tumbled by 97.07% to $302046.0 in 2024, then jumped by 1700.49% to $5.4 million in 2025, then surged by 68.48% to $9.2 million in 2026.
- Business Quant data shows HIND's Current Assets at $9.2 million in Q1 2026, $5.4 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 8.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.15 Mn |
| Mar 31, 2026 | 9.16 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Sep 30, 2025 | 6.04 Mn |
| Jun 30, 2025 | 8.86 Mn |
| Mar 31, 2025 | 6.30 Mn |
| Dec 31, 2024 | 302,046.00 |
| Sep 30, 2024 | 5.34 Mn |
| Jun 30, 2024 | 6.09 Mn |
| Mar 31, 2024 | 7.90 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Sep 30, 2023 | 7.40 Mn |
| Jun 30, 2023 | 10.54 Mn |
| Mar 31, 2023 | 15.23 Mn |
| Dec 31, 2022 | 9.91 Mn |
| Sep 30, 2022 | 13.26 Mn |
| Jun 30, 2022 | 19.17 Mn |
| Mar 31, 2022 | 23.31 Mn |
| Dec 31, 2021 | 29.94 Mn |
| Sep 30, 2021 | 37.27 Mn |